Football star Rob Gronkowski is partnering with Abacus Health (ABAHF), a publicly traded CBD company listed in Canada, the maker of CBDMEDIC.
“I’m an investor in CBDMedic,” Gronkowski told Yahoo Finance from the floor of the New York Stock Exchange. “It’s a topical cream with CBD in it — it has pharmaceutical grade ingredients.”
Gronkowski said his father introduced him to the cream, which aims to ease muscle pain.
Perry Antelman, CEO of Abacus Health Products, pointed to the cream’s potential benefits for football players dealing with pain from sports-related injuries. “It would be fabulous for the NFL,” Antelman said. “To be clear, this has no marijuana in it — this is a topical product, it does not go into the blood stream, there’s no THC and it is non-psychoactive.”
Gronkowski and Abacus Health will launch a suite of CBD products in early 2020, the company said.
Gronkowski retired earlier this year after a successful NFL career with the New England Patriots.
He remained coy when asked about a possible return to the NFL.
“To come back, they’re going to have to legalize CBD in the NFL,” he said. “No matter what I say, people are still going to say I’m coming back —so, I’m coming back, but I’m not.”
Scott Gamm is a reporter at Yahoo Finance. Follow him on Twitter @ScottGamm.
More from Scott:
Trump slams Fed Chair Powell: 'He’s like a golfer who can’t putt'
S&P 500 will plunge another 15% by the end of this year: strategist
Why China’s falling yuan could be good for U.S. stocks: strategist
Verizon Q2 profit beats estimates, boosted by wireless growth
Here is how corporate stock buybacks are changing the earnings picture
Follow Yahoo Finance on Twitter, Facebook, Instagram, Flipboard, LinkedIn, and reddit.